Viewing Study NCT01892566


Ignite Creation Date: 2025-12-24 @ 4:08 PM
Ignite Modification Date: 2025-12-26 @ 12:02 AM
Study NCT ID: NCT01892566
Status: COMPLETED
Last Update Posted: 2023-07-07
First Post: 2013-06-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Using Mobile Health to Respond Early to Acute Exacerbations of COPD in HIV
Sponsor: Johns Hopkins Bloomberg School of Public Health
Organization:

Study Overview

Official Title: Using mHealth to Respond Early to Acute Exacerbations of COPD in HIV (mREACH)
Status: COMPLETED
Status Verified Date: 2023-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: mReach
Brief Summary: Investigators propose to develop methods to improve early identification of acute exacerbations of COPD (AECOPD) among HIV-infected individuals. Investigators hypothesize that earlier identification of acute exacerbations through in-home monitoring of respiratory symptoms, lung function and medication usage will allow appropriate intervention to reduce the morbidity associated with AECOPD. Therefore, the investigators propose using innovative mobile health (mHealth) applications to Respond Early to Acute exacerbations of COPD in HIV (mREACH). COPD is a co-morbidity of HIV with growing recognition, but remains greatly under-recognized among HIV-infected persons. In this application, among HIV-infected individuals with spirometry-confirmed COPD, investigators will conduct a pilot randomized trial of mHealth monitoring compared to usual care to reduce the symptom and clinical burden of AECOPD.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
R34HL117349 NIH None https://reporter.nih.gov/quic… View